Effectiveness of Two Therapeutic Approaches in Female Teachers With Voice Disorders
NCT ID: NCT01196611
Last Updated: 2017-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
162 participants
INTERVENTIONAL
2010-09-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Voice Rehabilitation Program Compared With Vocal Function Exercises
NCT02409758
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
NCT01097161
Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology
NCT05220982
RCT Face-to-face Group Voice Therapy vs Telepractice Group Voice Therapy for Muscle Tension Dysphonia
NCT06524193
Voice Therapy for Teachers With Voice Problems
NCT00222937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Function Voice Exercises
Behavioral: Function Voice Exercises Patients will receive 6 sessions of therapy over a course of 6 weeks, with one session per week.
Function Voice Exercises
Function Voice Exercises Patients will receive 6 sessions of therapy over a course of 6 weeks, with one session per week.
Voice amplification
Behavioral: Voice amplification Patients will use VA over a course of 6 weeks.
Voice Amplification
Behavioral: Voice Amplification. Patients use VA over a course of 6 weeks Control group. No treatment over a course of 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Voice Amplification
Behavioral: Voice Amplification. Patients use VA over a course of 6 weeks Control group. No treatment over a course of 6 weeks.
Function Voice Exercises
Function Voice Exercises Patients will receive 6 sessions of therapy over a course of 6 weeks, with one session per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 21-50 years old.
* Full or part time elementary to middle school teacher ( Prefeitura Municipal de Belo Horizonte).
* Minimum 20 hour weekly workload.
* Medical reference to speech therapy due to behavioral dysphonia
Exclusion Criteria
* Professional singers.
* Neurological and/or psychiatric voice disorders
21 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Minas Gerais
OTHER
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leticia Caldas Teixeira
Professor/PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mara S Behlau, PhD
Role: STUDY_DIRECTOR
Universidade Federal de São Paulo
Arnaldo L Colombo, PhD
Role: STUDY_DIRECTOR
Federal University of São Paulo
Letícia C Teixeira, MsC
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Ana Cristina C Gama, D
Role: STUDY_DIRECTOR
Federal University of Minas Gerais
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de Sao Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ETIC 0521.0.203.000-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.